TY - JOUR
T1 - Longitudinal Evaluation of Visual Function in Multiple Sclerosis
AU - Narayanan, Divya
AU - Cheng, Han
AU - Tang, Rosa A.
AU - Frishman, Laura J.
N1 - Publisher Copyright:
Copyright © 2015 American Academy of Optometry.
PY - 2015/10/1
Y1 - 2015/10/1
N2 - PURPOSE: To evaluate longitudinal changes of visual function in relapsing-remitting multiple sclerosis (RRMS). METHODS: Multifocal visual evoked potential (mfVEP), contrast sensitivity (CS), and Humphrey visual fields (HVFs) were obtained at two visits (mean follow-up, 1.5 [±0.9] years) in both eyes of 57 RRMS patients (53 eyes with optic neuritis [ON]: 14 ON within 6 months of first visit [ON <6 months] and 39 ON ≥ 6 months; 57 non-ON). Longitudinal changes were assessed using mfVEP amplitude (log signal-to-noise ratio [logSNR]), latency, CS, and HVF mean deviation based on established 95% tolerance limits of test-retest variability. RESULTS: A significant percentage of eyes in the ON <6 months group exceeded 95% tolerance limits for mfVEP logSNR (21%, p <0.05), latency (35%, p <0.01), and CS (31% p <0.001); more improved than worsened over time (14% vs. 7% for logSNR, 21% vs. 14% for latency, and 31% vs. 0% for CS). Multifocal visual evoked potential latency decreased in 11% of non-ON eyes and in 10% of eyes in the ON ≥ 6 months group, and increased in 21% and 10%, respectively (p <0.01 for all). Latency changes correlated negatively with baseline latency (r = −0.43 and −0.45 for non-ON and ON ≥ 6 months; p = 0.0008). Although a nonsignificant percentage of non-ON and ON ≥ 6 months eyes exceeded tolerance limits for logSNR, CS, or HVF, logSNR and latency changes correlated, and both measures correlated with changes in CS (r = 0.47 to 0.79, p <0.01). CONCLUSIONS: Multifocal visual evoked potential, particularly latency, is potentially useful for assessing neuroprotective and remyelinating strategies in RRMS.
AB - PURPOSE: To evaluate longitudinal changes of visual function in relapsing-remitting multiple sclerosis (RRMS). METHODS: Multifocal visual evoked potential (mfVEP), contrast sensitivity (CS), and Humphrey visual fields (HVFs) were obtained at two visits (mean follow-up, 1.5 [±0.9] years) in both eyes of 57 RRMS patients (53 eyes with optic neuritis [ON]: 14 ON within 6 months of first visit [ON <6 months] and 39 ON ≥ 6 months; 57 non-ON). Longitudinal changes were assessed using mfVEP amplitude (log signal-to-noise ratio [logSNR]), latency, CS, and HVF mean deviation based on established 95% tolerance limits of test-retest variability. RESULTS: A significant percentage of eyes in the ON <6 months group exceeded 95% tolerance limits for mfVEP logSNR (21%, p <0.05), latency (35%, p <0.01), and CS (31% p <0.001); more improved than worsened over time (14% vs. 7% for logSNR, 21% vs. 14% for latency, and 31% vs. 0% for CS). Multifocal visual evoked potential latency decreased in 11% of non-ON eyes and in 10% of eyes in the ON ≥ 6 months group, and increased in 21% and 10%, respectively (p <0.01 for all). Latency changes correlated negatively with baseline latency (r = −0.43 and −0.45 for non-ON and ON ≥ 6 months; p = 0.0008). Although a nonsignificant percentage of non-ON and ON ≥ 6 months eyes exceeded tolerance limits for logSNR, CS, or HVF, logSNR and latency changes correlated, and both measures correlated with changes in CS (r = 0.47 to 0.79, p <0.01). CONCLUSIONS: Multifocal visual evoked potential, particularly latency, is potentially useful for assessing neuroprotective and remyelinating strategies in RRMS.
KW - Contrast sensitivity
KW - Multifocal visual evoked potential
KW - Multiple sclerosis
KW - Optic neuritis
KW - Remyelination
KW - Visual function
UR - http://www.scopus.com/inward/record.url?scp=84942626587&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84942626587&partnerID=8YFLogxK
U2 - 10.1097/OPX.0000000000000684
DO - 10.1097/OPX.0000000000000684
M3 - Article
C2 - 26267060
AN - SCOPUS:84944320353
SN - 1040-5488
VL - 92
SP - 976
EP - 985
JO - Optometry and Vision Science
JF - Optometry and Vision Science
IS - 10
ER -